Bioventus Inc.
BVS
$6.55
$0.121.87%
NASDAQ
| 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.87% | 78.33% | 78.14% | 75.81% | 87.68% |
| Total Depreciation and Amortization | -13.19% | -28.66% | -47.63% | -8.70% | 8.64% |
| Total Amortization of Deferred Charges | -16.67% | -16.67% | 50.46% | 50.46% | 50.46% |
| Total Other Non-Cash Items | 132.74% | -57.71% | -65.33% | -66.33% | -82.25% |
| Change in Net Operating Assets | -8.52% | -270.32% | -390.78% | -224.35% | -247.01% |
| Cash from Operations | 271.86% | 152.83% | 192.22% | -37.09% | -31.32% |
| Capital Expenditure | 62.35% | 86.34% | 92.30% | 66.83% | 54.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -28.83% | -28.83% | -100.64% | -100.64% | -- |
| Other Investing Activities | 100.00% | 93.84% | 93.84% | 93.84% | 98.85% |
| Cash from Investing | -22.55% | 45.27% | -113.33% | 91.03% | 123.55% |
| Total Debt Issued | 0.00% | -- | -100.00% | -69.39% | -74.58% |
| Total Debt Repaid | 12.50% | 31.72% | 87.93% | 78.89% | -126.69% |
| Issuance of Common Stock | 177.27% | 213.88% | -12.10% | 2.68% | -73.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -37.95% | 161.48% | 52.17% | 50.68% | -121.54% |
| Cash from Financing | 15.24% | -104.78% | 63.40% | -137.42% | -172.62% |
| Foreign Exchange rate Adjustments | -321.81% | -507.00% | -109.82% | -159.04% | -129.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.19% | -9.93% | 315.05% | 122.43% | 38.32% |